Stem Cell Transplantation With NiCordĀ® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
Gamida Cell ltd
Gamida Cell ltd
Dana-Farber Cancer Institute
University of Iowa
Children's Hospital of Philadelphia
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
Pfizer
St. Jude Children's Research Hospital
Therapeutic Advances in Childhood Leukemia Consortium
Dana-Farber Cancer Institute
Stanford University
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
University of Pennsylvania
Amgen
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Janssen Research & Development, LLC
Thomas Jefferson University
Thomas Jefferson University
University of Pennsylvania
Pfizer
IDeA States Pediatric Clinical Trials Network
Fred Hutchinson Cancer Center
City of Hope Medical Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Pfizer
University of Nebraska
Sellas Life Sciences Group
Edwards Lifesciences
Stanford University
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust
M.D. Anderson Cancer Center
Children's Oncology Group
City of Hope Medical Center
M.D. Anderson Cancer Center
Amgen
Amgen
Amgen
Children's Oncology Group
M.D. Anderson Cancer Center
City of Hope Medical Center
Aarhus University Hospital
Novartis
Novartis
Therapeutic Advances in Childhood Leukemia Consortium
University of Iowa
University of Alabama at Birmingham